4 doctors weighed in:

What is the newly approved hypoglycemic drug?

4 doctors weighed in
Dr. Stanley Schwartz
Internal Medicine - Endocrinology
2 doctors agree

In brief: Canagloflozin

Invokana is a novel drug that prevents reuptake of glucose from the kidney, so that you just shed more glucose out via the kidney.
Not effective with kidney disease, creatinine clearance <45. Drops hga1c ~0.8, both fasting and after-eating sugars. Must drink lots of liquids to prevent dizziness low blood pressure and, to reduce risk of urine infections, push fluids andkeep fastidious bathroom.

In brief: Canagloflozin

Invokana is a novel drug that prevents reuptake of glucose from the kidney, so that you just shed more glucose out via the kidney.
Not effective with kidney disease, creatinine clearance <45. Drops hga1c ~0.8, both fasting and after-eating sugars. Must drink lots of liquids to prevent dizziness low blood pressure and, to reduce risk of urine infections, push fluids andkeep fastidious bathroom.
Dr. Stanley Schwartz
Dr. Stanley Schwartz
Thank
Dr. Tony Ho
Internal Medicine - Infectious Disease

In brief: Invokana

Invokana is a novel drug that prevents reuptake of glucose from the kidney, so that you just shed more glucose out via the kidney.
There are some concerns about it about long term cancer risk, as well as use in patients with kidney disease, so more studies are pending.

In brief: Invokana

Invokana is a novel drug that prevents reuptake of glucose from the kidney, so that you just shed more glucose out via the kidney.
There are some concerns about it about long term cancer risk, as well as use in patients with kidney disease, so more studies are pending.
Dr. Tony Ho
Dr. Tony Ho
Thank
Get help from a real doctor now
Dr. Steven Seres
Board Certified,
19 years in practice
498K people helped
Continue
111,000 doctors available